Semi-Annual Report — FY2026 H1
What Kubota Pharmaceutical Holdings Co.,Ltd. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-14View the original on EDINET
How much it says
60Detailed
What moved here
25named for the first time
Its own wording
34terms
Which filing this is
33/ 33newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period, the company launched a subscription-based sales program for the myopia-progression care device Kubota Glass®, and, following execution of the supply and license agreement with Laboratoires KÔL for emixustat hydrochloride, entered into a supplemental memorandum, began manufacturing the active pharmaceutical ingredient and received the milestone consideration. It also carried out a capital reduction and deficit offset in April 2026.
Komori's summary of this document, not the document's own words.60Detailed
How much this filing saysA weighted roll-up of 9 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 34 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
61
Detailed
49
Typical
50
Typical
68
Detailed
55
Typical
53
Typical
79
Very detailed
50
Typical
R&D spend3億円Money spent making new things.
Cash left over-6億円Cash from the business, less what went into equipment.
Spent on equipment12百万円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.